AIM4ALL is a ground-breaking initiative working to move the industry from retrospective data collection to prospective, contract-driven evidence generation.

Built on work undertaken in the UK Health System under the Access to Innovative Medicines for All (AIM4ALL) Initiative, it provides:

Data Quality: Standardised, longitudinal datasets derived from routine clinical care.

Integration: Built atop existing systems without replacing infrastructure or burdening clinicians.

Governance: Governed by explicit “contracts for data collection” (defining scope, quality, timing, use).

Sovereign Deployment: Architectured for multi-jurisdiction, sovereign deployment from day one.

An extensible, standards-based solution progressing from de-identified data to consented, patient-centred services.